Abstract
Abstract not available. This study was sponsored by Amgen Inc. and medical writing support was funded by Ortho Dermatologics.
Cite
CITATION STYLE
APA
Menter, A., Sobell, J., Silverberg, J. I., Lebwohl, M., Rastogi, S., Pillai, R., & Israel, R. J. (2018). Long-Term Efficacy of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: Data from a Pivotal Phase 3 Clinical Trial. SKIN The Journal of Cutaneous Medicine, 2, S9. https://doi.org/10.25251/skin.2.supp.9
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free